![Ross Moat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Moat
No open positions remaining
Net worth: 581 963 $ as of 31/05/2026
Profile
Ross Moat currently works at Kiniksa Pharmaceuticals Ltd. as Chief Commercial Officer & Senior Vice President since 2022.
Mr. Moat also works at Kiniksa Pharmaceuticals International Plc as Chief Operating Officer & Executive Vice President starting in 2026.
Former roles include General Manager at Synageva BioPharma Corp.
and VP-EMEA Marketing & Commercial Operations at Novartis Gene Therapies, Inc. from 2018 to 2019.
Education includes an undergraduate degree from Middlesex University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.03% | 09/04/2026 | 12,029 ( 0.03% ) | 581 963 $ | 31/05/2026 |
Ross Moat active positions
| Companies | Position | Start |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Corporate Officer/Principal | 01/02/2021 |
Former positions of Ross Moat
| Companies | Position | End |
|---|---|---|
| AVEXIS INC | Sales & Marketing | 01/06/2019 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | - |
Training of Ross Moat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Middlesex University
 Middlesex University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Ross Moat
